Spectrum Pharmaceuticals, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
03 nov. 2022 17h16 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...